The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Dysregulation of neural iron is known to occur during the progression of Alzheimer's disease. The visualization of amyloid‐beta (Aβ) plaques with MRI has largely been credited to rapid proton relaxation in the vicinity of plaques as a result of focal iron deposition. The goal of this work was to determine the relationship between local relaxation and related focal iron content associated with Aβ plaques. Alzheimer's disease (n = 5) and control tissue (n = 3) sample slices from the entorhinal cortex were treated overnight with the iron chelator deferoxamine or saline, and microscopic gradient‐echo MRI datasets were taken. Subsequent to imaging, the same slices were stained for Aβ and iron, and then compared with regard to parametric R2* relaxation maps and gradient‐echo‐weighted MR images. Aβ plaques in both chelated and unchelated tissue generated MR hypo‐intensities and showed relaxation rates significantly greater than the surrounding tissue. The transverse relaxation rate associated with amyloid plaques was determined not to be solely a result of iron load, as much of the relaxation associated with Aβ plaques remained following iron chelation. The data indicate a dual relaxation mechanism associated with Aβ plaques, such that iron and plaque composition synergistically produce transverse relaxation.Copyright © 2014 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Self-citationThe effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
The Haber–Weiss reaction and mechanisms of toxicity
Kehrer, J. P. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00231-6 · Cited by 1,418 · cited 1×
“Specifically, the catalytic reduction of iron to Fe and oxidization to Fe in these cyclical reactions produce highly reactive hydroxyl radicals (20,21).”
Regulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986 · cited 1×
“Iron uptake in the brain and storage are tightly regulated through coordinated homeostatic transcriptional and translational regulation of proteins, such as divalent metal transporter 1, ferroportin, transferrin, transferrin receptor, iron regulatory protein and ferritin (1,2).”
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
Metal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310
Coordinate Transcriptional and Translational Regulation of Ferritin in Response to Oxidative Stress
Tsuji, Y., Ayaki, H., Whitman, S. P., Morrow, C. S., Torti, S. V., & Torti, F. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.5818-5827.2000 · Cited by 285
Meadowcroft, M. D., Connor, J. R., Smith, M. B., & Yang, Q. X. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21731 · Cited by 176
Self-citationCollingwood, J. F., Chong, R. K. K., Kasama, T., Cervera-Gontard, L., Dunin-Borkowski, R. E., Perry, G., Pósfai, M., Siedlak, S. L., Simpson, E. T., Smith, M. A., et al. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14211 · Cited by 147 · cited 1×
“The increased concentration of iron in the brain tissue of patients with Alzheimer’s disease (AD) has been well demonstrated (5,6), and a close association of iron with amyloid-beta (Aβ) plaques has been established in AD tissue (7,8).”
Cited by
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J., Morris, M. C., & Bush, A. I. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0375-7 · Cited by 365
Chen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200
McIntosh, A., Mela, V., Harty, C., Minogue, A. M., Costello, D. A., Kerskens, C., & Lynch, M. A. (2019) · Brain Pathology · doi:10.1111/bpa.12704 · Cited by 196
“Similar areas of hypointensity were identified in slices of entorhinal cortex obtained from AD patients and these were significantly greater in areas of Aβ accumulation compared with the surrounding tissue but persisted to some extent even after the tissue was treated with the iron chelator, deferoxamine (23).”
Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179
Telling, N. D., Everett, J., Collingwood, J. F., Dobson, J., van der Laan, G., Gallagher, J. J., Wang, J., & Hitchcock, A. P. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.07.014 · Cited by 169
“It is therefore possible that the presence of iron in AD tissue could be used as a diagnostic tool (Acosta-Cabronero et al., 2013; Antharam et al., 2012; Dobson, 2001; El Tannir El Tayara et al., 2007; Meadowcroft et al., 2009, 2014; Wang et al., 2014).”
Metadata
- Authors
- Meadowcroft, M. D., Peters, D. G., Dewal, R. P., Connor, J. R., & Yang, Q. X.
- Venue
- NMR in Biomedicine
- Publisher
- Wiley
- Published
- 2014-12-22
- Volume
- 28
- Issue
- 3
- Pages
- 297-305
- ISSN
- 0952-3480 (ISSN-L)
- 1099-1492
- OpenAlex
- W2122236448
- Cited by
- 48
- References
- 13
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease. https://app.cochat.ai/papers/10.1002/nbm.3247
- The paper
- Meadowcroft, M. D., Peters, D. G., Dewal, R. P., Connor, J. R., & Yang, Q. X. (2015). The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease. NMR in Biomedicine. https://doi.org/10.1002/nbm.3247
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.